Sign inJoin waitlistJoin the waitlist

Matthew Sims

Director · Corewell Health

Credentials: · · · · · · ·

History

Corewell Health
Present

Infectious Disease
University of Rochester Medicine
2003–2005
Internal Medicine
Stony Brook Medicine
2000–2003
SUNY Downstate University Health Sciences University College of Medicine
1996–2000

Research

SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
New England Journal of Medicine · 2022 · 459 citations
Bile salt hydrolase acyltransferase activity expands bile acid diversity
Nature · 2024 · 146 citations
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With…
Clinical Infectious Diseases · 2020 · 140 citations

LM
Lisa von Moltke
7 papers
BM
Barbara Mcgovern
6 papers
Stuart Cohen
6 papers
Vance Fowler
6 papers
AH
Alexandra Halalau
5 papers
Anwaruddin Syed
5 papers · 4 as a fellow
AP
Ashok Palagiri
5 papers
Charles Berenson
5 papers
Colleen Kraft
5 papers
Marcus Zervos
5 papers
Thomas Holland
5 papers
AD
Alon Dagan
4 papers

Clinical trials

Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections
Principal investigator · Withdrawn
Novozymes A/S
2023–2024
ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)
Principal investigator · Terminated · Phase 2
Corewell Health East
2020
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19
Principal investigator · Terminated · Phase 2
Corewell Health East
2020–2021
Screening to Prophylax Against Clostridium Difficile Infection -
Principal investigator · Completed · Phase 4
Corewell Health East
2016–2023